IPGA Today 2020 new · 29 Pharmacy colleges of Delhi NCR and 12 colleges outside Delhi NCR with an...
Transcript of IPGA Today 2020 new · 29 Pharmacy colleges of Delhi NCR and 12 colleges outside Delhi NCR with an...
For private circulation amongst members only.www.ipga.in
NEWSLETTER OF INDIAN PHARMACY GRADUATES' ASSOCIATION
Special Issue 2020 RNI No. : DELENG/2013/51512
IPGA TODAYPANACEA 2020
From the Desk of President
S. L. Nasa
Mr. Ravi Uday Bhaskar
S. L. Sobti
Prof. (Dr.) G.N. Singh
Prof. (Dr.) R. K. Khar
Prof. (Dr.) S. S. Agrawal
Prof. (Dr.) M.D. BurandeProf. (Dr.) B.G. Shivananda
Prof. (Dr.) Dr. B. Suresh
S. W. DeshpandeProf. (Dr.) S. K. Kulkarni
Advisory Board
P. P. Sharma
Prof. (Dr.) Shahid Ansari
Mr. Shirish DabadeProf. (Dr.) Kamla Pathak
Prof. (Dr.) Javed Ali
Prof. (Dr.) Satyendra K Rajput
Ms. Zeba Khan
Prof. (Dr.) Vijay Bhalla
Editor in Chief
Ms. R. Mathangi
P. K. Jaggi
Editorial Board
Anil Kr. NegiDr.Arti R. Thakkar
Dr.Neerupma Dhiman
It is really tormenting to see the situation nowadays where the cases of the COVID-19 are increasing day by day all around the globe. More than Eighty nine lakh people have been affected and almost three lakh people have died across in over 200 countries. Although humanity is not witnessing such a pandemic for the first time earlier being Cholera, bubonic plague, smallpox, influenza, Spanish Flu to name a few but the present epidemic is also quite serious and deadly. The COVID-19 outbreak has created a lot of serious challenges to India's healthcare community. Many “New Normal” have been observed in various fields of Pharmacy profession and human life in general. We have observed that various colleges and universities have adopted online mode of education due to lockdown and hence helped in maintaining the social distancing. Similarly, many already existing pharmaceutical and cosmetics manufacturing firms have commenced manufacturing hand sanitizers just to fulfill the need of the present situation. It has been observed that many pharmaceutical companies are reinventing themselves to survive and even looking for new opportunities in terms of developing COVID-19 related diagnostic kits, high quality face masks, Personal Protection Equipment, affordable ventilators and interactive apps for delivering medications as well as tracking the COVID-19 patients. The current scenario has taught us that the Pharmaceutical Industry should be self-reliant, so that the API and other raw materials for the industry can be prepared in our own country and we need not rely on the other countries for their imports. The Central Government has already committed to support the Pharmaceutical Industry in more than one way If we are able to rise to the occasion then it will be the beginning of a new era for India's healthcare and pharmaceutical sector since India is already considered to be the Pharmacy of the world. Many safe and best practices have been proposed across India. The key points such as social distancing, wearing of mask, frequently washing our hands, resilience, hope and compassion for the deprived are considered to be the “New Normal” to keep the low rate of spread of the disease.
In this situation of distress and depression, IPGA had recently conducted the first online conclave which included the major areas related to the profession of Pharmacy ranging from Pharmaceutical Industry to IPR, to Research and Development and to Academia with the aim to boost the morale of the Pharmacy professionals belonging to different fields of Pharmacy. The IPGA student forum had also recently conducted an event named Panacea 2020 in collaboration with DIPSRU, in which the students of 29 Pharmacy colleges of Delhi NCR and 12 colleges outside Delhi NCR with an average footfall of 900 students had participated. The event was full of fun, sports, innovation and research activities. IPGA has initiated the IPGA-Women Forum for strengthening the Women Pharmacist in the profession. Lot of activities has been planned in that context too.
I am sure this issue of IPGA Today will provide you with the detailed information on the various professional activities of our association for the community and society we are living in. Stay Safe and Stay Healthy.
Editorial�Board
is Official NewsletterPublished & Produced by
Indian Pharmacy Graduates' AssociationF-2, A Block, DDA Shopping Complex,
Meera Bagh, New Delhi-110087
‘ The IPGA TODAY’
T DAYIPGA
Atul Kumar NasaPresident- IPGA
Managing Trustee- IPGA Welfare TrustVice President –AIDCOC
01
Inside :
Circulars 15-28
Scientific & New Drugs 29-30
Industry Updates 31-33
Seminar Report 34
Women's Forum Updates 35-36
Tribute to Padma Shree
Editor-in-Chief 02
Invited Articles 03-08
Student Activities 09-14
Gazette Notification and
From the Desk of President 01
From the Desk of
Prof. (Dr.)Harkrishan Singh 37-40
IPGA New Members 41-43
IPGA WELFARE TRUST 44
From the Desk of Editor-in-Chief
As the number of members of our Association increased, the idea of publication of IPGA TODAY was mooted way back in the early eighties with a view to convey information about the various activities of IPGA to all its members. It was published with a view to develop the faculties of practicing Pharmacists, keep them abreast with the recent advances in different fields of Pharmacy and also to improve their awareness. With the formation of IPGA WELFARE TRUST and the Students' Wing of IPGA, relevance of publishing IPGA TODAY increased manifold. Initially IPGA TODAY used to be printed and sent through post to all the members located in different parts of the country. Due to various factors IPGA TODAY now-a-days is hosted on the website of IPGA for quick dissemination of information to all its members in a digital format and also save on the scarce resources. I am confident that with the recent induction of young turks in its Editorial Board IPGA TODAY is bound to be better in design, content and usefulness.
Let us all pray and hope for an early break through to stop the ongoing pandemic for the sake of saving the human race.
Stay in, Stay Safe and Stay Strong. No doubt that 'Tough times don't last, Tough people do'.
My Greetings to all the members of IPGA family.
With no immediate signs of developing a vaccine against the Covid 19 virus, researchers in the Pharmaceutical and Health care Industry are already working overtime on the off-label use of various drugs including but not limited to Anti-Retroviral drugs like Remdesivir, Favipiravir, anti-malarial drugs like Hydroxychloroquine, Blood products for providing Plasma therapy and so on. The scientific and regulatory bodies in India like CSIR and DCGI are also putting in their extra efforts in clearance of research projects which are expected to lead to an early break through for an appropriate method of stopping the onslaught of Covid 19 virus.
To my belief Pharmacy as a subject, even as of date, provides very exciting opportunities in different fields ranging from Manufacturing, Analysis, Research, Sales and Distribution of Drugs and Pharmaceuticals apart from offering jobs in the field of Education and many other related fields. In the context of the present situation of COVID 19 pandemic all over the globe, the importance of Pharmacy as a subject has gained even more importance. With India having established itself as Pharmacy of the world, more avenues for Pharmacists in different sectors are opening up particularly in the field of research for newer drugs and Community Pharmacy. The Central Government has already announced several incentives for the rapid growth of the Pharmaceutical industry. With the changing environment of the health care more job opportunities for the Pharmacists are expected. However, it is imperative that there will be newer challenges and expectations of the co-health workers, patients as well Government bodies which, I am confident, in due course of time we will be able to overcome..
T DAYIPGA
PK JAGGIB Pharm LLB MBA
02
The pharmacy sector horizons are expanding,
mirroring the various developments impacting the
healthcare industry as a whole. This can widely be
attributed to the recent advancements of innovation
and technology. These changes have enabled the
pharmacist to take greater role and responsibilities
being a member of the patient's primary care team.
Advancements in healthcare technology continue to
lead innovations in retail and ambulatory pharmacy.
New health information technology (HIT) and the
increasing awareness and use of robotic dispensing
systems have made pharmacy operations faster and
more efficient, while at the same time improving
patient safety. Technology innovations have also led
to more streamlined and coordinated workflows,
which are helping pharmacies, optimize operations
throughout their entire drug delivery cycle.
The pharmaceutical industry is unique in several
ways in terms of the elaborate requirements for the
Health sector market. The pharmaceutical market
value is anticipated to grow approximately USD 1.1
trillion by 2021 globally. In this age of rapid
innovation in the technology, new opportunities and
fields are emerging continuously which are able to
provide better health care and management.
Integration of biotechnology and computer science
with pharmaceutical sector added great impact in
pharmaceutical research and development techniques
ranging from discovering new therapeutic molecules
on one end to providing patient customized treatment
which ultimately increases the patient outcome. This
article briefly describes latest techniques and
developments in Pharmaceutical and Biomedical
Research.
Increasing on-boarding of tech solutions is allowing
pharmacies to offset mounting economic realities,
which continue to shrink profit margins across all
pharmacy sectors. Automation solutions, which
include everything from robotic systems to integrated
workflow and pharmacy softwares, are enabling
pharmacies to re-prioritize resources. This allows
them to expand value-added offerings such as
telepharmacy services, long-term care, and mail
order, as well as improve efficiencies based on
centralized service models.
Figure 1: Expanding Horizons of the Pharmacy
Profession.
1. ARTIFICIAL INTELLIGENCE
Artificial Intelligence (AI) refers to utilisation of
computer systems or automated algorithm to perform
task which was previously dependent on human
intelligence. It saves human time, cost, effort and
provide better management and presentation of data.
Now a day's artificial intelligence tools are being used
at all the stages of drug discovery and development.
Artificial intelligence is also used in diagnosis of
disease by defining the effect of particular feature on
the disease, prediction of epidemic outbreaks as in
case of malaria, in distinguishing normal cells with
EXPANDING HORIZONS OF PHARMACY PROFESSIONShikha Baghel Chauhan, Vaishnavi Gupta
Amity Institute of Pharmacy, Amity University, Noida (U.P.) 201303
Invited Article
03
Nanotech-nology
ArtificialIntelligence
3D Printing
m Health Sensors
Organ-on-chip
Precision medicine
Drug discovery in the field of Oncology.
Drug discovery and synthesis
Oncology focussed health records
Breast cancer clinical trial
Analysis of Clinical trial operation
Personalised therapy for macular
degeneration and drug design
Prediction of dementia neurodegenerative
disease.
Development of Insilco drug discovery uit
Development of Biomedical medicine
Pfizer with IBM Watson
Pfizer with Massachusetts Institute of Technology
Roche with Flatiron Health
Novartis with IBM Watson
Novartis with McKinney’s
Novartis and Microsoft
Johnson and Johnson with Winter light Lab
Glaxo Smith Kline
Glaxo Smith Kline with Google
S.No. Company Year Purpose
2016
2018
2018
2017
2018
2019
2018
2019
2017
1
2
3
4
5
6
7
8
9
Invited Article
04
the cancerous cells. Artificial intelligence has
enormous role in pharmaceutical industry by making
everything streamlined by maintaining and analyzing
data and conducting repetitive task. Pharmaceutical
industry is adapting artificial intelligence in
collaboration with specialized artificial intelligence
driven companies and also by developing inner
expertise. Examples of Pharmaceutical Industry
using Artificial Intelligence are described in Table 1.
Table 1: Pharmaceutical Industry using Artificial Intelligence
2. PRECISION MEDICINE
These medicines consider individual patient
differences with the objective of right drug to the right
patient at the right time to improve the patient
condition and reduce the adverse effect associated
with it. As we all know that effect of any drug i.e. its
onset of action, absorption and metabolism is
different among us due to difference in individual
person at molecular and genetic level. Therefore,
precision medicine development can be defined as an
approach which combine the molecular and clinical
information to determine biological basis of disease.
In this technique, data is obtained from gene
sequencing and then this data is further used for
identification of gene abnormalities and effect of drug
in different patients. Few examples of Precision
Medicine are mentioned in Table 2.
Table 2: Precision Medicine
Chronic myeloid leukaemia
Lung Cancer
Breast Cancer
Colon cancer
Melanoma
BCR-ABL
ALK
HER-2/neuroreceptor
EFGR
BRAFV6006
S.No. Biomarker Drug name Disease condition
Gleevec
Xalkori
Herceptin
Erbitux
Zelboraf
1
2
3
4
5
Invited Article
05
5. m- HEALTH SENSORS
Smartphone have advanced processors and sensors
that can record information which are essential in the
post market studies and allow easy participation of
subjects in the studies. As more and more people
participate in such studies more data is collected and
that helps in producing more accurate result
enhancing better representation of the population.
Therefore, this technique has unique ability to engage
more people. It is not only limited to smart phones or
smart watches (Apple watch, Samsung gear) and
fitness bands. These sensors are capable of taking
biometric reading and are more advanced, accurate
and possess huge potential for collecting clinical trial
information in real world in real time settings. They
have sensors that can detect blood glucose,
temperature, heart rate, sleep, blood oxygen and
various other parameters. However, without internet
the information or data collected cannot be synced
with devices of researchers and doctors. m-Health
sensors are nowadays being used by pharmaceutical
industries in clinical research. m-Health sensors has
created shift in clinical research organizations
towards remote monitoring and reduced unnecessary
requirement of visiting hospital or research centre
during the clinical trial. Recently APPLE iPhone has
developed several applications for conducting
research on cardiovascular disease, diabetes and
asthma.
International Standard Organization (ISO) has
defined 3-D Printing as “fabrication of object through
rapid disposition of the material using printhead
nozzle or any other technology”. 3-D Printing is
basically manufacturing process which produces
three-dimensional solid dosage form by successive
addition of material layer by layer with the help of
computer aided model. This process allows delivery
of higher dosage of medicine up to 1000 mg and
produce porous pills which dissolve rapidly, thus,
providing better patient compliance. This technique is
gaining lot of importance due to rapid preparation and
can be utilized in developing novel dosage forms.
Some example of 3-D printed dosage form includes
implants, microneedles, orodispersable tablets,
floating and multicompartment tablets. Recently,
FDA approved first 3D printed epilepsy drug Spritam
by Aprecia Pharmaceuticals.
Organ-on-chip (OOC) is an alternative to traditional
testing and has solved various ethical issues
associated with preclinical studies. Generally, cell
line culture has semi-static conditions and doesn't
have the actual organ function, that's why prediction
of drug efficacy and toxicity became difficult.
Microchips lined by human cells are microfabricated
and are based on microfluidic device technology and
hence, can be used as novel organ model. They
actually mimic the function of different organs and a
3. 3-D PRINTING
Nanotechnology is one of the most rapidly growing
discipline in the pharmaceutical industry. It refers to
design, produce, characterize, structures or system
which are in nano size range from 1 to 100nm. These
are designed to deliver diagnostic and therapeutic
molecular substance across the biological barrier and
can detect small molecular changes. They overcome
several limitations of conventional dosage forms such
as low bioavailabity. From several examples Genexol
- PM by Samyang which is a lyophilized, sterile
polymeric micellar nanomedicine of paclitaxel for
breast cancer and small lung cancer.
Researchers are now developing a technology that
can track the medication after consumption. These
systems would provide information to physician and
are combination of nanotechnology and robotics
known as nanorobots taken in the form of pills and
injection and are effective against cancerous cells or
to perform surgical task.
6. Organ-on-chip
4. NANOTECHNOLOGY
Invited Article
06
1. Dayal P, (2018 Jul,24)16 Tech Advancements in
Pharmaceuticals to Reinvent healing.
http;//www.newsgenapps.com/blog/tech
advancements in pharmaceuticals to -re-invent
healing.
Conclusion:
2. Arsene C, (2019 May 4) Artificial Intelligence
& Pharma: What Next? http;//www.
Digitalauthority.me/resoures/artificial
intelligence-pharma/
It is pertinent to mention that pharmaceutical
industries are adopting digital technology to meet the
specific needs of their patients. It can be understood
that pharmaceutical industries nowadays not only
focus on selling the drug and medication but are also
concerned and inclined in adopting and implementing
latest technology and gadgets, thereby widening the
scope of the pharmacy profession.
References:
4. Jamroz W, 3-D printing in pharmaceutical and
medical applications- recent achievements and
challenges. Pharm Res..2018;35,(176);2-22
group of tissue like lung, liver, kidney, gut and
ultimately connect all systems building a whole-body
model. Ingber Research group had developed
“breathing lungs” having a two-layered channel
s t r u c t u r e s e p a r a t e d b y m i c r o p o r o u s
polydimethylsiloxane membrane (PDMS). They
have alveolar epithelial cells on the upper surface of
the membrane and vascular endothelial cell on the
lower membrane and also uses culture media and
flowing air to mimic lung structure and by managing
the internal and external pressure on both the sides,
thereby, maintaining the physiological contraction
and relaxation. The study proved that nanoparticles
uptake was increased when contraction movements in
the blood vessels were increased and similar results
were produced when similar study was conducted on
the rats.
5. Kimura H, Sakai Y, Fujji T; `Organ / body on a
chip based on microfluidic technology for drug
discovery.
Drug Metabolism and Pharmacokinetics;2018;
33:43-48
3. Kumar S, Emerging trends in pharmaceutical
sciences: An introduction to nanotechnology.
World journal of pharmaceutical
sciences.2014;12(2):1592-93
IT JUST TAKES FEW MINUTES
FOR YOU TO SAVE FOUR LIVES
07
Corona viruses (CoV) are a family of viruses that can
cause illnesses such as the common cold, severe acute
respiratory syndrome (SARS) and Middle East
respiratory syndrome (MERS). Corona viruses are
zoonotic, i.e. they are transmitted between animals
and humans. A novel corona virus (nCoV) is a new
strain that has not been identified in humans so far.
The virus is now known as the severe acute
respiratory syndrome corona virus 2 (SARS-CoV-2).
The disease it causes is called corona virus disease
2019 (COVID-19). The 2019 novel corona virus
(2019-nCoV; severe acute respiratory syndrome
corona virus 2 (SARS-CoV-2)) has spread rapidly
since its recent identification in patients with severe
pneumonia in Wuhan, China. As of 10th February
2020, 2019-nCoV has been reported in many
countries across different continents and >40,000
cases have been confirmed, with an estimated
mortality risk of ~2%. (2). WHO declared COVID 19
as global health emergency on 30th January 2020
followed by global pandemic on 11th March
2020.The data for the COVID 19 patient till 21st of
April stood at 2, 397 217 confirmed cases and 162 956
deaths and figures still rising unrelentleessly.
Characteristics of 2019-nCoV
2019-nCoV is an enveloped, positive-sense, single-
stranded RNA beta-corona virus. Similar to SARS
and MERS, the 2019-nCoV genome encodes non-
structural proteins (such as 3-chymotrypsin-like
protease, papain-like protease, helicase, and RNA-
dependent RNA polymerase), structural proteins
(such as spike glycoprotein) and accessory proteins (
Fig. 1) (1)
Invited Article
OVERVIEW ON COVID-19 Neerupma Dhiman1 and Arti Thakkar1
1Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida 201 313
Fig. 1
Invited Article
08
Symptoms
Unfortunately, no specific drug or vaccine has yet been approved to treat this human corona viruses. Initial analyses of genomic sequences from 2019-nCoV indicate that the catalytic sites of the four 2019-nCoV enzymes that could represent antiviral targets are highly conserved and share a high level of sequence similarity with the corresponding SARS and MERS enzymes. Furthermore, protein structural analyses suggest that key drug-binding pockets in viral enzymes are probably conserved across 2019-nCoV, SARS and MERS3. It is, therefore, reasonable to consider existing MERS and SARS inhibitors for 2019-nCoV.
However, new interventions are likely to require months or even years to develop to prove their worth. Given the urgency of the 2019-nCoV outbreak, the existing antiviral agents approved or in development for treating infections caused by HIV, hepatitis B virus (HBV), hepatitis C virus (HCV) and influenza, based on therapeutic experience with two other infections caused by human corona viruses: severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) are used(1) .
Who are at risk of this disease?
1) Nature Reviews Drug Discovery 19, 149-150 (2020)2) World Health Organization guidelines.
e) Avoid sharing dishes, glasses, bedding and otherhousehold items, if you're sick.
c) Stay away from the person who is showing the symptoms of the infection.
How Corona virus spreads
Human corona viruses most commonly spread from an infected person to others:a) By coughing and sneezingb) By touching or shaking handsc) Touching an object or surface contaminated with virus
Common signs of infection includes respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. But in severe cases, the symptoms include pneumonia, severe acute respiratory syndrome, kidney failure and even death.
d) Avoiding the crowded places.
f) Clean and disinfect surfaces you often touch.
Currently there is no vaccine available to protect humans from corona virus but the prevention to this disease can be attained by reducing the transmission through:
g) Stay home from work, school and public areas, if you're sick.
a) Washing hands with warm water and soap or we can use alcohol based sanitizers.
h) Avoid eating raw or undercooked meat or animal organs.
Older people and those with pre-existing medical conditions (such as cardiovascular disease, chronic respiratory disease or diabetes) are comparatively at
greater risk for severe disease.
I) Avoid contact with live animals and surfaces they may have touched if you're visiting live markets in areas that have recently had new corona virus cases.
b) Avoiding touching eyes, nose and mouth with unwashed hands.
Treatment for COVID-19
Prevention
Several options can be envisaged to control or prevent emerging infections of 2019-nCoV, including vaccines, monoclonal antibodies, oligonucleotide-based therapies, peptides, interferon therapies and small-molecule drugs. Plasma therapy has also shown promising results in certain cases.
What to do if symptoms of infections are seen in any person in the family or in the neighborhood
Do not panic, call the emergency number for COVID in your area and they will take the person to the hospital with precaution and start the treatment. Infection with this disease does not necessarily results in death.
References:
With an immense amount of hard work and persistence that goes into organizing any event, we as an organization can stand tall and proud as we proclaim the success of this event which would have been nothing without the prodigious efforts of Shri Atul Kumar Nasa, President, IPGA along with the entire IPGA council team.
It was organized as a two day event on 29th February and 1st March 2020 at Delhi Pharmaceutical Sciences and Research University, New Delhi and was filled with jam packed scientific and academic events in juxtaposition with spectacular cultural competitions all of which gained momentum with a tremendous amount of participation from students all across the nation, coming together to celebrate a fest like no other.
Panacea saw an overwhelming response from 29 colleges of Delhi NCR and 12 colleges outside Delhi NCR with an average footfall of 900 students. It also included the participation of the IPGA Student Forum-Bihar Chapter.
PANACEA - India's First Pharma Fest which encompassed the entire Pharmaceutical fraternity across the country in its fold was a collaborative effort organized by Indian Pharmacy Graduates' Association- Student Forum (IPGA-Student Forum), Indian Pharmacy Graduates' Association (IPGA), Delhi Pharmaceutical Sciences and Research University and DPSR University Alumni Association.
The fest was also a hub of delicious food. Brands famous for fast food like LaPino'z, SadakChaap, South Indian Food Stall showcased their presence.
Panacea was also filled with fun games set up by the students of different colleges.
The fest was also joined by professional actors and Nukkad Natak specialists like Mr. Tarun Kohli, Mrs. Reeta Sharma, dancers like Ms. Arushi Solanki and Mrs. Shalini Solanki, Composers and Youtubers like Mr. Bali Kashyap, Celebrated poets like Mr. Aditya Mudgal, Women Entrepreneurs like Ms. Vaishvi Lakhina, Stylists like Ms. Samyukta, National Winner of EuroArts - Mr. Abhinav Sadana.
Lastly, we would also like to thank all the students and teachers who joined our event and contributed to its success. We will forever be in gratitude for their understanding, kindness and keenness to see all the wonders this event entailed and for allowing us to dream big and succeed.
PANACEA 2020-THE FESTIVAL OF DREAMS
STUDENTS ACTIVITIES
09
SPONSORS FOR THE EVENT:
STUDENTS ACTIVITIES
10
DAY ONE OF PANACEA 2020
Dr. Harvinder Popli, Principal-DPRSU also
enlightened the students and other faculty members of
DPSRU with her enchanting words and reminded us
the importance and need of a pharmacy centered
event such as Panacea 2020. The event concluded
with the release of our magazine –FARMAKON 2.0
The event commenced with the Inauguration
ceremony by felicitating Professor Dr. RK Goyal,
Vice-Chancellor, DPSRU, Shri Atul Kumar Nasa,
President, IPGA,Dr. Harvinder Popli, Principal and
Registrar, DPSRU and Dr. Arun Garg, General
Secretary, IPGA.
The President of IPGA-SF, Ms. Prabhleen Pahwa
commenced the ceremony with a welcome address
which was followed by an inspiring speech by Shri
Atul Kumar Nasa, President, IPGA and an
illuminating and encouraging speech by Prof. Dr. RK
Goyal-Vice Chancellor of DPSRU that resonated
with all present during the inauguration.
Events:
The day began with our first event, Nukkad Natak
which was made into a great success by 16
participating teams from all across Delhi NCR and
other states. Our esteemed judge for the event, Mr.
Tarun Kohli bestowed the students with enthusiasm
and reflected his passion for acting and drama onto
everyone present to witness the acts into play.
The winning teams, tied into first position were
Dhwani (ANDC) & Kranti (IINTM). The thought
provoking themes taken up by the teams and their
ability to involve the entire audience into a state of
internalization is what led the day into an
interesting start.
STUDENTS ACTIVITIES
11
Goonj, our group singing competition was next and
packed with beautiful voices resonating throughout
the campus. Our judge for the event was with our
winners - Nukul khanna & Shivam Ahuja.
“Present Your Mind At Silicon Gully” was another
interesting event with an impressive display of ideas
that are translated into something tangible - a product
or a service; this is what separates doers from
thinkers. Silicon Gully was all about innovation and
ideas that can change the way this industry works. We
congratulate our Winning Team: Avantika Bhatia and
Shriyani Roy and extend a special thanks to Mr.
Nitesh Chauhan and Dr. Harvinder Popli for judging
the event.
The young bright minds brought their distinction
from the rest of the crowd by finding solutions to
problems like no other. Eureka was an event made
precisely for such minds. A special thanks to our
judges, Ms.Bushra and Mr. Mayank Dhawan. We are
proud of our Winner- C S Sruthi from DPSRU.
“Eureka was a very new and unconventional event, where participants come up with policies that can fix the problems overlooked in pharmacy. Thanks for having me there as a judge. Great work. Keep it up” -
Ms. Bushra Shameem
The stage was shaking with the vibrant energy of the
dancing teams in Oorja and Utkarsh, our solo and
group dance competitions with esteemed judges Ms.
Arushi Solanki and Mrs. Shelina Solanki.
“It was a great honor to judge dance competition at the
event Panacea! The volunteers were hardworking
and took great care of us. We got amazing hospitality
and the event was well organized by the organizers. It
was a great experience being a part of the event and
would be glad to be a part of it in the coming future”-
Ms. Arushi Solanki and Mrs. Shalini Solanki.
STUDENTS ACTIVITIES
12
RANGEELA was one of the events to encourage young
artistic minds to show their creativity on the topic
"TRANQUILLITY". We are proud to announce our winner-
Muskan Verma- Maitreyi College, University Of Delhi. A
very special thanks to our judge Mr. Abhinav Sadana and
Prof. Sharad Wakode for selecting the best artist amongst
some very tough competition.
Sometimes you can find peace of mind by transferring
yourself to different situations. They are just reminders to
stay calm. While art therapy is one of the ways to stay calm
and bring out inner peace.
Mr.Ravie Solanky, the founder of The Social House and our
winners Darakshan Praveen from DIPSAR University. The
day ended with mind-blowing performances by bands
during Ride the Lightning competition which shook the
entire crowd with its music
The Hindi poetry competition, Alfaz brought us laughter,
tears and a new found admiration for people who can tangle
words into a beautiful web of poems that touched our souls.
A special thanks to our judge,
The Best Time to Take Walk for DiabeticsA surprising news that taking a
walk before eating brings down
the blood glucose levels. But
whether we take a walk before or
after food or both will bring down
the sugar levels.
The researchers have found that
intense physical activity (fast
walks) before meals help people
with insulin resistance to control
their blood glucose levels better
than the standard recommenda-
tion to get one daily 30 minutes
of moderate exercise.
Walk for 25 minutes, five days a
week is recommended. Walking is
also good for pre-diabetics in
controlling sugar levels.
Taking a walk after dinner is the
best for diabetics but before
dinner is still better.
STUDENTS ACTIVITIES
13
DAY TWO OF PANACEA 2020
Dramaturgy brought in some of the most amazing
teams with though revoking subjects that ranged from
poverty to politics. Our winning team Hansraj
College and Deshbandhu College (Dramanomics)
with our Best actor Yash (MAC) and Special mention
Samagra (MAIMS).
Knock-out saw an intense battle between
perspectives and ideas. With topics extending from
healthcare as a business propaganda to the immense
problems involving population control, our winners
battled head to head for the ultimate prize. We
congratulate our winners Tannu Dhingra (NIET) and
extend our special thanks to Dr. Aarti Thakkar for
lending her precious time to judge our participants.
Rap Battle: The Rap battle had no rules, themes,
limitations and boundaries. The rap battle saw an
overwhelming response with participants that stirred
up the crowd in a frantic anticipation to see who
Later in the evening, the most awaited event came
into action, Panacea 2020 Fashion show – Styled to
rock. We saw some amazing contestants with fashion
forward style and a walk that lit up the entire stage.
We congratulate the winners of Fashion show who
were adjudged as, Ms. Panacea: Varsha from SGT
University and Mr. Panacea: Lalit also from SGT
University.
We are very thankful to our judges Ms. Vaishvi
Lakhina and Ms. Samyukta for investing their time
and skills into our venture.
will win as participants went head to head against
each other in a battle of words, mind and speed.
Our winner- Ranvir Kumar (SGT University) was
one such contestant who impressed the judges and the
audience alike with his immaculate skills.We thank our judge Mr. Bali Kashyap
for his feedback on the event.
STUDENTS ACTIVITIES
14
Pharm Junkies (Quiz) the activity of brainstorming yourself to bring out the right answers. It was a game of accuracy and precision. Essentially comprising of elements of a standard quiz format but with a twist in terms of its applicability. The questions were no longer restricted to a theory-based foundation but rather forced the participants to scavenge their minds like a true Pharmacist by testing the practical applicability of their knowledge.
Our winning team: Anuj, Kushi and Sagar from DIPSAR University.
Sci-con consisted of visual display of research/review findings of the students in the form of a self – explanatory and unambiguous poster which ended up with a question and answer session with the individual involved. This event was judged by dignitaries including Dr. Shruti Chopra, Dr. Arun Garg, Dr. Amit Kumar and Dr. Swaminathan.
Our other events included PUBG battle and Snapshot, a photography event which concluded the events we had for PANACEA 2020.
Special mention and thanks to all our Sponsors for their whole hearted support and motivation in making this event
a grand success.
IPGA ADVISORY
Corona Virus – CoVid-19 Infection
Can mul�vitamins and immuno-boosters help in protec�ng individuals from the virus?
It is true that our physiology requires vitamins and minerals (such as vitamin A, C and zinc) to func�on normally. Higher doses have not been shown to make the system func�on be�er.
Every part of the body, including the immune system, func�ons be�er when protected from environmental assaults and bolstered by healthy-living strategies such as the following: • Not smoking; • Ea�ng a diet high in fruits and vegetables; • Exercising regularly; • Maintaining a healthy weight; • Avoiding drinking alcohol, or drinking only in modera�on; • Ge�ng adequate sleep; • Taking steps to avoid infec�on, such as washing hands frequently and cooking meats adequately;
• Trying to minimise stress. Stay Home Stay Safe
FAQs
Gazette Notification and Circulars
15
Gazette Notification and Circulars
16
17
Gazette Notification and Circulars
18
Gazette Notification and Circulars
19
Gazette Notification and Circulars
IPGA ADVISORY TO PHARMACISTS
Corona Virus 2019-nCoV InfectionExpert Consensus on Guidance and Preven�on Strategies for hospital pharmacists and
the pharmacy workforce :Source::Chinese Pharmaceu�cal Associa�on, Feb 6th 2020
The pharmacy department shall disinfect the poten�al contaminated objects periodically ,including object surfaces, the air, hands and prescrip�ons.
Object to be disinfected Type of disinfec�on drugs
Environmental object surface
Chlorine-containing disinfectant (1000mg/L), chlorine dioxide (500mg/L), 75% alcohol, etc.
Hands Alcohol-containing quick-drying hand disinfectant, chlorine-containing disinfectant,
hydrogen peroxide.
Skin 0.5% iodine-based disinfectant, hydrogen peroxide.
Mucosa 0.05% iodine-based disinfectant
Indoor air Per-ace�c acid, chlorine dioxide, hydrogen peroxide, etc.
Pollutant Chlorine-containing disinfectant (5000-20000mg/L),
disinfectant powder or bleach powder containing water absorp�on
Tex�les such as
clothes, bedding Chlorine-containing disinfectant(500mg/L), ethylene oxide
Prescrip�ons Ethylene oxide
20
Gazette Notification and Circulars
Gazette Notification and Circulars
21
IPGA ADVISORY
Corona Virus – CoVid-19 Infection
1. Alloca�on of addi�onal human resources to arrange shi�s to avoid overwork of pharmacists.
2. Pharmacists should be encouraged to consume a healthy diet.
3. To perform regular ac�ve health status monitoring, including checking body temperature and respiratory symptoms.
4. To adopt all measures to ensure pharmacists stay healthy while providing pharmacy services to pa�ents.(Use Mask, Hand hygiene, Sani�za�on, PPE etc.)
5. Pay a�en�on to the mental health & their emo�onal management.
6. Conduct mental counselling.7. Protect pharmacy staff from the infec�on
Circular
22
Circular
23
Circular
24
Circular
25
Circular
26
IPGA ADVISORY
Corona Virus – CoVid-19 Infection
1. Ensure safety and con�nuity of services2. Opening hours should be communicated and
displayed to the public at a visible place . 3. Contact with pa�ents/customers should be minimised
by dispensing medicines through a small window4. The boxes /cases used by wholesale distributors for
the delivery of medicines should be cleaned and disinfected before they are taken inside
5. Home delivery may be offered for pa�ents who may be have been advised home quaran�ne or isola�on, or who may belong to a higher risk group or have reduced mobility/or for pa�ents older than 65 years
6. Have adequate stocks of essen�al medicines and devices
7. Do not overcharge for any medicine8. Carry out full staff training Patient First
Circular
27
Circular
28
Tazverik by Epizyme Inc.
Tepezza by Horizon Therapeutics Ireland DAC
Tazverik (tazemetostat) is the first drug approved by FDA on 23 January, 2020 for the treatment of epithelioid sarcoma, a rare soft tissue cancer. Tazverik (tazemetostat) for the treatment of adults and pediatric patients aged 16 years and older with metastatic (when cancer cells spread to other parts of the body) or locally advanced (when cancer has grown outside the organ it started in, but has not yet spread to distant parts of the body) epithelioid sarcoma not eligible for complete resection (surgically removing all of a tissue, structure, or organ). Epithelioid sarcoma is a rare sub-type of soft tissue sarcoma that often occurs in young adults. The most common side effects for patients taking Tazverik were pain, fatigue, nausea, decreased appetite, vomiting and constipation.
Tepezza (teprotumumab-trbw)is the first drug approved for the treatment of thyroid eye disease. It is used for the treatment of adults with thyroid eye disease, a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to be pushed forward and bulge outwards (proptosis).The US FDA approved this drug on 21 January, 2020. The most common adverse reactions observed in patients treated with Tepezza are muscle spasm, nausea, alopecia (hair loss), diarrhea, fatigue, hyperglycemia (high blood sugar), hearing loss, dry skin, dysgeusia (altered sense of taste) and headache.
Trikafta by Vertex Pharmaceuticals
Adakveo by Novartis
The U.S. Food and Drug Administration granted approval to Givlaari (givosiran) on 20 November 2019 for the treatment of adult patients with acute hepatic porphyria, a genetic disorder resulting in the buildup of toxic porphyrin molecules which are formed during the production of heme (which helps bind oxygen in the blood). “This buildup can cause acute attacks, known as porphyria attacks, which can lead to severe pain and paralysis, respiratory failure, seizures and mental status changes. These attacks occur suddenly and can produce permanent neurological damage and death. Common side effects for patients taking Givlaari were nausea and injection site reactions. Givlaari also received Orphan Drug designation, which provides incentives to assist and encourage the development of drugs for rare diseases.
Fetroja by Shionogi & Co., Ltd.
The U.S. Food and Drug Administration approved Trikafta (elexacaftor/ivacaftor/tezacaftor) on 21 October 2019 .It is the first triple combination therapy available to treat patients with the most common cystic fibrosis mutation. Trikafta is approved for patients 12 years and older with cystic fibrosis who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator
(CFTR) gene, which is estimated to represent 90% of the cystic fibrosis population.
It is an antibacterial drug for treatment of patients 18 years of age or older with complicated urinary tract infections (cUTI), including kidney infections caused by susceptible Gram-negative microorganisms, who have limited or no alternative treatment options. The U.S. Food and Drug Administration approved Fetroja (cefiderocol)on 14 November 2019. The most common adverse reactions observed in patients treated with Fetroja included diarrhea, constipation, nausea, vomiting, elevations in liver tests, rash, infusion site reactions, candidiasis (yeast infection), cough, headache and hypokalemia (low potassium).
It is the first targeted therapy approved for painful complication of sickle cell disease. It was approved on 15 November 2019. It is used to reduce the frequency of vaso-occlusive crisis – a common and
Givlaari by Alnylam Pharmaceuticals.
SCIENTIFIC AND NEW DRUGS UPDATES
Scientific & New Drugs
29
30
Scientific & New Drugs
Padcev is a potent anticancer drug which got FDA approval on 18 december 2019 .This drug is used in the treatment of refractory bladder cancer . Padcev (enfortumabvedotin-ejfv), a Nectin-4-directed antibody and microtubule inhibitor conjugate, meaning the drug specifically targets cancer cells – in this case, the cell adhesion molecule Nectin-4, which is highly expressed in urothelial cancers. Padcev is indicated for the treatment of adult patients with locally advanced (when cancer has grown too large to be surgically removed) or metastatic (when cancer cells spread to other parts of the body) urothelial cancer.
Xycopri bySK Life Science Inc.
This drug was approved on 25 November 2019 by US FDA. Oxbryta in which the active ingredient is voxelotor is used for the treatment of sickle cell disease (SCD) in adults and pediatric patients 12 years of age and older. Oxbryta is an inhibitor of deoxygenated sickle hemoglobin polymerization, which is the central abnormality in sickle cell disease. Common side effects for patients taking Oxbryta were headache, diarrhea, abdominal pain, nausea,
fatigue, rash and pyrexia (fever).Oxbryta also received Orphan Drug designation, which provides incentives to assist and encourage the development of drugs for rare diseases.
Oxybryta by Global Blood Therapeutics.
Padcev by Astellas Pharma US Inc.
The U.S. Food and Drug Administration approved XCOPRI (cenobamate tablets) on 21 November 2019 to treat partial-onset seizures in adults.“XCOPRI is a new option to treat adults with partial-onset seizures, which is an often difficult-to-control condition that can have a significant impact on patient quality of life. XCOPRI should not be used in patients with hypersensitivity to cenobamate or any of the inactive ingredients in XCOPRI or Familial Short QT syndrome. QT shortening can be associated with ventricular fibrillation, a serious heart rhythm problem. The most common side effects that patients in the clinical trials reported were somnolence (sleepiness), dizziness, fatigue, diplopia (double vision), and headaches.
painful complication of sickle cell disease that occurs when blood circulation is obstructed by sickled red blood cells – for patients age 16 years and older. Adakveo specifically inhibiting selectin, a substance that contributes to cells sticking together and leads to vaso-occlusive crisis. Common side effects for patients taking Adakveo were back pain, nausea, pyrexia (fever) and arthralgia (joint pain).
Reyvow byEli Lilly and Company
The U.S. FDA approved Reyvow (lasmiditan) tablets on 11 October 2019. It is used for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. There is a risk of driving impairment while taking Reyvow. Patients are advised not to drive or operate machinery for at least eight hours after taking Reyvow, even if they feel well enough to do so. The drug causes central nervous system (CNS) depression, including dizziness and sedation. The most common side effects that patients in the clinical trials reported were dizziness, fatigue, a burning or prickling sensation in the skin (paresthesia), and sedation.
Torrent Pharmaceuticals puts faith in local
market, to focus on new drug launches:
The growth trajectory for the Indian pharmaceutical
industry is likely to remain at 10-13 per cent in 2020-
21 despite challenges, according to rating agency
ICRA. According to ICRA, The expected growth in
the next financial year is on the back of healthy
demand from the domestic market given increasing
spend on healthcare along with improving access.
This along with abatement in pricing pressure for the
US market, new launches and market share gains for
existing products and consolidation benefits will
drive growth in 2020-21, it added.
Glenmark sells gynac business for Rs 115 crore:
Glenmark Pharma has sold its gynaecology business
to private equity firm True North backed Integrace
Pharma in an attempt to cut down debt of the
company. The sale of the gynac business comes two
years after it sold its orthopedic business to the same
company. Integrace will pay Rs 115 crore for four
products of the portfolio that includes products like
Dubagest, Mumfer and Fenza. These three products
currently have sales of Rs 60 crore and are growing by
15%.
Eli Lilly, Sitryx announce autoimmune alliance:The Ahmedabad-based company, part of the Rs
14,000-crore Torrent Group, is the only domestic
pharma co that has invested nearly $1 bn in local
acquisition over the last three years. It expects its
future growth avenues from India, Brazil and
Germany. The company also focuses on the launch of
products in the segment of cardiology and diabetes,
which is the fastest growing segment in India. Torrent
Pharmaceuticals is optimistic that the future of Indian
drug makers is in the domestic market, as it looks at
new launches in the lucrative chronic therapy areas.
Eli Lilly has revealed a new global licensing and
research collaboration with Sitryx, in order to study
up to four novel preclinical targets identified by. The
collaboration is set to grant Lilly an exclusive,
worldwide license to develop and commercialise up
to four novel immunometabolism targeted
therapeutics, including Sitryx's two lead projects,
leading to a a five-year research collaboration to
support the development of the therapeutics. The
companies have confirmed that under the terms of the
agreement, Sitryx will receive an upfront payment of
$50 million, and Lilly will make a $10 million equity
investment in Sitryx. Also, the latter will be eligible to
receive potential development milestones up to $820
million, as well as commercialisation milestones and
royalty payments on potential sales in the mid- to
high-single digit range.
Unichem, Macleods recall drugs for blood
pressure, diabetes from US market:
Unichem is recalling 1.91 crore units of Clonidine
Hydrochloride tablets from the US market because of
failed impurities/degradation specifications. This
recall is initiated as a precautionary measure due to
potential migration of Benzophenone at very low
level into product from container label, the United
States Food and Drug Administration(USFDA) said
and Macleods is recalling 4,694 bottles of
Pioglitazone and Metformin Hydrochloride tablets
used for treating high BP because of subpotent drug:
out of specification assay result, below specification,
for two lots of Pioglitazone And Metformin
Hydrochloride tablets, the USFDA said.
Indian pharma industry likely to grow at 10 to 13
per cent in FY'21 ICRA:
PHARMACEUTICAL INDUSTRY UPDATES
Industry Updates
31
32
SkanRay, the leading ventilator manufacturer has
created a consortium with BEL, BHEL & Mahindra to
ramp up production from standard 2000 pieces per
month to currently 5000 pieces per month and 30,000
pieces per month by May.
Dyson, a bagless vacuum cleaner and hand sanitizer
company is working alongside The Technology
Partnership to develop its new system, called The
CoVent. It has already begun work at the RAF
Hullavington technology campus after receiving an
initial order of 10,000 units from the UK government
and will donate another 5,000 to the international
effort. The device is safe, effective, efficient in
conserving oxygen, easy to use, bed-mounted,
portable and not needing a fixed air supply. CoVent
meets the clinician-led specifications, to address the
explicit clinical needs of COVID-19 patients.
Various Liquor manufacturers and sugar mills have
stepped forward to meet the increasing demands of
sanitizers. Jagatjit Industries that makes liquor
brands such as Aristocrat whisky has initiated the
manufacture and supply of sanitizers. Chennai-based
packaged consumer goods company CavinKare
launched hand sanitizers under its popular personal
care brands – CHIK, Nyle, and Raaga. Jubilant Life
Sciences announced that its research and
development team has developed formulation for
hand sanitizer using ethanol produced at its plants.
Dr Reddy's to acquire part of Wockhardt's India
business for Rs 1,850 crore:
Dr Reddy's Laboratories on Wednesday announced
an agreement with Wockhardt Ltd. to acquire select
divisions of its branded generics business in India,
Nepal, Sri Lanka, Bhutan and Maldives for a
consideration of Rs 1,850 crore. The agreement
comprises a portfolio of 62 brands in multiple therapy
areas such as respiratory, neurology, VMS,
dermatology, gastroenterology, pain and vaccines.
Wockhardt will transfer Dr Reddy's related sales and
marketing teams; and the manufacturing plant located
in Baddi, Himachal Pradesh with all plant employees.
The business undertaking is being transferred on a
slump sale basis, according to the company.
1. Medical Devices like ventilators
Various medical equipment manufacturers have
joined hands with automotive industries to fasten the
production of ventilators for the critically ill patients.
Indian medical device manufacturers have drawn up
plans to deliver 50,000 ventilators by May to meet the
growing demand for life-saving devices during the
COVID-19 outbreak.
AgVa has tied up with Maruti to scale up production
from 400 pieces per month to 4000 pieces per month
in April to 10,000 pieces per month by May.
2. Sanitizers
Seeing the surge in the demands of sanitizers, various
companies have also reduced prices of their sanitizer
brands to make it more accessible and affordable.
3. Testing Kits manufactured in India
Under Mylab's, research and development chief,
Minal Dakhave Bhosale, the corona virus testing kit
called Patho Detect was developed in just six weeks.
Mylabs Discovery Solutions, which received
statutory approvals from authorities, can manufacture
over 15,000 testing kits per day from its facility at
Lonavala in Pune district and the same will be ramped
up to 25,000 kits per day.
4. Drugs and vaccines
Various big pharma companies have put forth their
plans and means of fighting this pandemic through the
development of vaccines and drugs. Some of them
have been indicated below-
a. Gilead is working on the Remdesivir for
treatment of COVID-19 patients. It has initiated two
Industry Updates
33
Industry Updates
c. AbbVie collaborating with health authorities and
institutions globally to determine antiviral activity as
well as efficacy and safety of KALETRA®/Aluvia
(lopinavir/ritonavir), AbbVie's antiretroviral therapy
for the treatment of HIV, against COVID-19.
h. Japanese pharma giant Takeda is at work on a
treatment derived from the blood of people who have
already been infected by the corona virus. The
company is drawing blood from corona virus
survivors, harvesting the plasma, and then isolating
the protective antibodies that kept those patients
alive.
e. Arcturus Therapeutics and Duke-NUS Medical
School (Duke-NUS) partner to develop a Corona
virus (COVID-19) vaccine for Singapore. The
development of a COVID-19 vaccine will be based on
the company's STARR technology and will take
advantage of a unique platform developed at Duke-
NUS allowing rapid screening of vaccines for
effectiveness and safety.
d. Moderna is developing a vaccine- mRNA-1273
that was identified just 42 days after the novel corona
virus was sequenced. The company is working with
the National Institutes of Health on a healthy-
volunteer study that began earlier this month.
I. Gujarat-based company Zydus is a leading
producer of hydroxychloroquine (HCQ) and it has
already increased its capacity to make both the API
and the formulation manifold.
g. Eli Lilly has partnered with a Canadian firm called
AbCellera to develop antibody treatments for corona
virus infection. Using a blood sample from a corona
virus survivor, AbCellera identified more than 500
antibodies that might protect against the virus.
f. CureVac uses man-made mRNA to spur the
production of proteins. It got a grant from the
nonprofit Coalition for Epidemic Preparedness
Innovations to apply its technology to corona virus.
CureVac expects to start the clinical trial Phase I by
early summer 2020.
Phase 3 trials to evaluate the safety and efficacy of
remdesivir in adults diagnosed with COVID-19
following the U.S. Food and Drug Administration's
(FDA) rapid review and acceptance of Gilead's
investigational new drug (IND) filing. These
randomized, open-label, multicenter studies began
enrolling patients in March 2020 and will enroll a
total of approximately 1,000 patients in the initial
phase of the studies, in countries with high prevalence
of COVID-19.
b. Pfizer collaborates with BioNtechfor the
development of the new mRNA vaccine initially to
supply in the United States and Europe and scale-up
manufacturing capacity to support global supply of
millions of vaccine doses by the end of 2020 subject to
technical success of the development program and
approval by regulatory authorities, and then rapidly
scale up capacity to produce hundreds of millions of
doses in 2021.
The Best Time to Take Walk for Diabetics
Walk for 25 minutes, five days a
week is recommended. Walking is
also good for pre-diabetics in
controlling sugar levels.
Taking a walk after dinner is the
best for diabetics but before
dinner is still better.
The researchers have found that
intense physical activity (fast
walks) before meals help people
with insulin resistance to control
their blood glucose levels better
than the standard recommenda-
tion to get one daily 30 minutes
of moderate exercise.
A surprising news that taking a
walk before eating brings down
the blood glucose levels. But
whether we take a walk before or
after food or both will bring down
the sugar levels.
Throwing light on the topic of Research Directions, Dr. Kanchan Kohli explained the role of ICMR and other Government funding agencies, Prof. (Dr.) Arun Garg, Professor Pharmacology and General Secretary of IPGA, discussed about under trial drug Remdesivir. Dr. Satyendra Kr. Rajput, Director Amity Institute of Indian Medicine encouraged all the participants to practice yoga, meditation and consume immunity boosting drinks and food to fight COVID-19.
Some of the illustrious dignitaries who were present all along the Conclave included Sh. Shripati Singh, Sh. Bharat Bhushan Dr Ajay Sachan, Dr. Jey Balan Govindaswamy, Dr. Rahul Garg, Dr Abhishek Singh and Dr. Neerupma Dhiman.
Ms. Silky Sethy concluded the session by proposing the vote of thanks..
The Conclave proved to be a very informative Webinar organized by IPGA in collaboration with Amity University and was well appreciated by the participants.
Indian Pharmacy Graduates'Association along with Amity University organized its First National Conclave Online on May 10, 2020. The conclave was enlightened by more than 25 experts and was participated by more than 1000 participants. The theme of the conclave was: : The next Generation Pharmacist: “Digitalization, The Regulatory Mechanisms, The Research Directions and Future Jobs”. It was chosen in the prevailing uncertainty amongst the students of pharmacy fraternity due to the Pandemic COVID-19. Dr Vijay Bhalla, convened the online webinar which was attended by more than 2300 participants.
On the topic Digitalization, Mr. B.R. Sikri, a renowned businessman and a successful Pharmaceutical Entrepreneur addressed the young pharmacists on the current scenario of Pharmaceutical industry vis a vis untapped opportunities in the making of a self reliant India.
While speaking on Regulatory Mechanisms Mr Pawan Kumar Jaggi, Ex-Head of Office, Drugs Control Department, Delhi enlightened the students on the role of Drug Control Officers in maintaining the supply chain during pandemic. Mr. Atul Kumar Nasa, President IPGA explained how the Govt. and Drug Control Departments both at center and state level are playing a dynamic role in fighting this Pandemic of Covid-19.
Dr. Vijay Bhalla, Dean, SGT University played an important role in organizing the conclave. Dr Bhalla , Dr M N Rao and Dr Arti Thakkar elaborated on the topic Future Jobs for young budding pharmacists.
Seminar Report
34
IPGA CONCLAVE 2020: NEXT GENERATION PHARMACIST Sunday, May 10th 2020
The main aim for the establishment of the IPGA-WF
is to provide a national platform enabling women
Pharmacists to expand pharmaceutical opportunities
and strengthen their role in the profession. Further it
was discussed and approved by the CEC members
that various awareness programmes related to women
health such as post-partum depression, pregnancy
care, menopausal issues diet & nutrition and other
related issues must be carried out throughout year.
The following hierarchy was approved for framing
the IPGA Women Forum.
In October 2019, Dr. Kanchan Kohli, Professor and
Head, Pharmaceutics, School of Pharmacy, Jamia
Hamdard, New Delhi and Dr. Arti R. Thakkar,
Associate Professor, AIP, Amity University, Noida
were unanimously selected as a Convener and co-
convener of the IPGA-Women Forum (IPGA-WF).
WOMEN'S FORUM UPDATES
Women's Forum
35
Further, In March, 2020 nominations were invited from across India for different positions of the Women Forum
Executive committee. After screening of the few applications following candidates have been selected on various
positions of the women forum central executive committee.
(As a women forum representative in working division of IPGA)1. Academic2. Industrial3. Pharmacy practice4. Public Relation5. Regulatory Affairs
Covener
Co-Covener
CouncilMembers (5)
ZonalCoordinators
Chair toSections
North South East West Central
StateCoordinator Co-cordinator
Convener
Co-Convener
PositionS.No. Names Designation
1
2
Dr. Kanchan Kohli
Dr.Arti R Thakkar
Professor and Head, Pharmaceutics, School of Pharmacy,
Jamia Hamdard, New Delhi
Associate Professor, AIP, Amity University, Noida
Council Members
1
2
3
Dr. Neerupma Dhiman
Dr. Kriti Soni
Ms. Archu Singh
Associate Professor, AIP, Amity University, Noida
Head, F&D, Dabur Research Foundation, Shahibabad, Gaziabad, UP, India
PhD Scholar, School of Pharmacy, JamiaHamdard, New Delhi.
Women's Forum
36
Central Zone
North Zone
South Zone
1
2
3
Dr. Kamala Pathak
Dr. Ramanpreet Walia
Dr. Sanju Dhawan
Professor, Faculty of Pharmacy, Uttar Pradesh University of
Medical Sciences, Saifai, UP
Associate Professor, AIP, Amity University, Noida
Head- Product Development IKKT, Pfizer Healthcare,
SIPCOT Industrial Park, Irungattukottai, Sriperumbudur (Tk),
Tamil Nadu, India
Zonal Coordinators
Panjab
Uttar Pradesh
Gujarat
Maharashtra
Uttar Pradesh
1
2
3
4
5
Dr. Prerna Swarup
Dr. Neeraj
Dr. Nikunjana Patel
Dr. Dipti Ruikar
Dr. Sarita Yadav
Principal, Swami Vivekanand College of Pharmacy,
Banur, Patiala, Panjab
Director, RPS College of Pharmacy, Barabanki, UP
Associate Professor, Shree S. K. Patel College of
Pharmaceutical Education and Research, Ganpat University,
Mehshana, Gujarat
HOD and Associate Professor, School of Pharmacy,
GH Raisoni University, Amravati, Maharashtra
Assistant Professor, Department of Pharmacy,
Moti Lal Nehru Medical College, Allahabad-UP
State Coordinators
If anyone is interested to be part of the IPGA Women Forum they can send their names, brief profile alongwith email
id for consideration and approval on the following email ID: [email protected]
Few positions such as East Zone and West Zone coordinators, different state coordinators and council members,
require to be filled.
BEST FOODS FOR DIABETICS1) CINNAMON : Research has suggested that cinnamon, in type-2 diabetes, helps to reduce blood glucose levels and increase insulin sensitivity. It improves insulin receptor function by activating enzymes that cause insulin to bind to cells (insulin receptor-kinase) and inhibits enzyme that blocks this process. 6 gms per day reduces LDL, Cholesterol and triglycerides. If 6 gms is taken for 40 days, can drop the blood glucose level by 25%.Best form is to brew cinnamon like tea and drink.
2) JAMMUN Total jammun fruit is very effective in diabetes. Seeds are rich in alkaloids which have hypoglycemic effect. They also increase insulin activity and sensitivity. 1 gm of powder taken three times a day can bring down the level of glucose by 30%.
3) ONION Contains high quantity of flavonoids (quercetin, cysteine, allyl propyl disulphide) which have the property to lower the sugar levels in diabetes.50 gms of onion extract as juice controls the post prandial glucose levels.
4) FENUGREEK SEEDS It contains fibers and chemicals which slows digestion of carbohydrates and sugar. It also increases the insulin release. 4, hydroxyleucine- a novel amino acid present in seeds increases glucose simulated insulin release by isolated islet cells.In the morning drink 10 gms of seeds soaked in hot water over night.
5) ALO-VERA Alo-vera is packed with glucomannan which reduces glucose levels. The other components like anthraquinones, organic phenols and
lectins also regulate the sugar levels. Alo-vera cleans the body and eliminates excess glucose in the blood stream. It stimulates the secretion of insulin from the pancreatic beta cells. Alo-vera juice 50 ml taken twice a day regularly for two months brings a substantial change in sugar levels.
6 ) B R O C C O L I B r o c c o l i c o n t a i n s phytochemical Sulforaphane which can reverse the damage diabetes inflict on the blood vessels. It is recommended for diabetics because it contains antioxidant, minerals, vitamins and low calories. Broccoli also contains chromium which is required for GTF ( glucose tolerance factor) thus helps to metabolize blood sugar. Broccoli should not be cooked but eaten in salads or stir fried.
Tribute
37
He was very keen to do Masters in Pharmacy. Professor N.K. Basu, Head of the Department of Pharmaceutics, Banaras Hindu University (BHU) accepted him for admission for the session starting in July 1951. The M. Pharm course at BHU was of one year duration and only by research. Professor Basu asked him to work on the chemical examination of Achyranthes aspera Linn. This was his first exposure to work on a medicinal plant and handling of a quaternary ammonium compound, Betaine. He completed his M. Pharm in May 1952 and got a good job in the industry. However, this yearning for further research made him to accept appointment at the BHU as a part-time lecturer. The appointment was only for a couple of months. He resigned a well-paid job in industry to join BHU in November 1952 on a salary of Rs. 180 per month. Luckily, he was appointed as a temporary lecturer in a leave vacancy. He joined the BHU faculty in February 1953 and continued in the position up to January 1956. During this period of lectureship, he also worked for his doctoral thesis, again under Prof. Basu.
Fraternity of Pharmacy was shocked to know about the sudden sad demise of Professor Harkishan Singh on 20 March, 2020. With his death, the Golden Sun of Pharmacy Profession has set forever. In India, no other pharmaceutical professional has done as much work as an academician, research scientist, historian and an active promoter of cause of pharmacy as Professor Singh.
He worked on the investigation of chemical constituents of Orthosiphon pallidus Royle, submitted his thesis in November, 1955 and got his Doctorate in 1956. He had published two papers in the Scientific Edition of Journal of American
Harkishan Singh was born on 25th November, 1928 in a village in Lyallpur district (now in Pakistan). He was the eldest of the five children of Shri Subeg Singh and Shrimati Kirpal Kaur belonging to the village Khara in Amritsar district. Shri Subeg Singh was in postal service and worked at different places in India, finally retired in 1963 from Hyderabad. He had done his matriculation and F.Sc. Intermediate from Panjab
University. In April 1948, Harkishan Singh joined B.Pharm at Medical College, Amritsar and obtained his B a c h e l o r ' s d e g r e e i n Pharmacy in 1950, standing first in the order of merit. Shortly after completing his d e g r e e , h e h a d t h e opportunity to work for a couple of months at the Drug Research Laboratories, Jammu, of which Col. Sir Ram Nath Chopra was the Director. It was a great privilege for him to be under
ththe tutelage of this great savant of the 20 Century.
A TRIBUTE TO GURU DEV : PROFESSOR HARKISHAN SINGHDr. T.R. Bhardwaj
(Vice-chancellor, Baddi University of Emerging Sciences and Technology, Baddi, Himachal Pradesh- Former Chairman, UIPS, P.U., Chandigarh).
Dr. T.R. Bhardwaj
Tribute
38
Dr. Singh served as Lecturer in Pharmaceutical Chemistry, Banaras Hindu University, 1953-1956; Assistant Professor of Pharmaceutical Chemistry, University of Sauger, 1956-1964; Reader in Pharmaceutical Chemistry, Panjab University, 1964-1972; Professor, Pharmaceutical Sciences (Pharmaceutical Chemistry), Panjab University, 1972-1988.
Dr. Singh got married in June, 1958. His wife Mrs Gian was a personality radiating warmth in relationship and concerned about the individual problems of all who-so-ever came in the contact of her. By virtue of her interest in social milieu, she had ever remained a key figure on the University campus. Prof. Singh's main source of strength and best companion was his wife, with whom he was happily married for 40 years. They had two children- Tript and Dr. Manjeet, both are settled in United States.
Dr. Singh spent around five academic years abroad working at Universities of Maryland, USA (1958-1961), Mississippi, USA (1967-1968) and London, UK (1971-1972). He was Head of the Department of Pharmaceutical Sciences, Panjab University (1976-1981) and Founder Dean of the Faculty of Pharmaceutical Sciences, Panjab University (1981-1985). He was also Dean of Alumni Relations, Panjab University (1979-1984). He was a National Fellow of the University Grants Commission (UGC) at the Panjab University (1985-1987), being the only person in Pharmaceutical Sciences to get this honour from the UGC.
POSITIONS HELD
Professor Harkishan Singh was conferred Padma Shri by President of India Hon'ble Pranab Mukherjee in 2017. He was conferred with almost all awards and honours for his research and professional contributions. He was the recipient of Illustrious Faculty Award, Diamond Jubilee Celebrations, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Vishwavidhyalaya, Sauger, M.P. 2016; Doctor of Science (Honoris Causa) conferred by the Panjab University, Chandigarh, 2016; Lifetime Achievement Award, Panjab Academy of Sciences, 2015; Doctor of Science (Honoris Causa) conferred by the University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA, 2014; Shri Raman Bhai B. Patel Foundation Lifetime Achievement Award, Indian Pharmaceutical Association, Mumbai, 2010; Lifetime Achievement Award, Indian Pharmaceutical Congress, Banaras Hindu University, 2007; Shri Bhojraj Panjamool Lifetime Achievement Award, Association of Pharmaceutical Teachers of India, 2007; Lifetime Achievement Award, Chandigarh Science Congress, 2007; Lifetime Achievement Award, Uttar Pradesh Technical University, 2006; elected Honorary Fellow, Panjab Academy of Sciences, 2001; Eminent Pharmacist Award, Indian Pharmaceutical Association, Mumbai, 1999; Schroff Memorial National Award, Indian Hospital Pharmacists' Association, New Delhi, 1998; elected member, Academic Internationale d' Histoire de la Pharmacie, 1995; Golden Jubi lee Commemoration Award, The Pharmaceutical and allied Manufacturers and Distributors Association Limited (PAMDAL), Bombay, 1991; Ranbaxy Research Award in Pharmaceutical Sciences of the Ranbaxy Research Foundation, New Delhi, 1987; National Fellow, University Grants Commission, 1985-1987; Professor G.P. Srivastava Memorial Award, Association of Pharmaceutical Teachers of India (APTI), 1983; Acharya P.C. Ray Memorial Gold Medal, Indian Pharmaceutical Association, Bengal Branch, Calcutta, 1982; Distinguished Alumnus Award, Institute of Technology, Banaras Hindu University; Shri Amrut Mody Research Foundation Award, Bombay, 1975. Professor
Pharmaceutical Association. These publications gave a good beginning to Dr. Singh to build his further research career. Dr.Harkishan Singh moved to the University of Sauger in 1956 to join as Assistant Professor of Pharmaceutical Chemistry. Later, in 1964, he joined Panjab University as a Reader rising to the position of Professor in 1972.
Dr.Harkishan Singh was Professor Emeritus Panjab University since 2003 and Emeritus Fellow (UGC) Panjab University, 1989-1992.
AWARDS AND HONORS
Tribute
39
OTHER PROFESSIONAL AND ACADEMIC RECOGNITIONS
RESEARCH
Professor Singh had been associated with the working of several professional and statutory organizations and held important position in these bodies. He was member of the Pharmacy Council of India (PCI) (1970 -1981, 1987 -1992); PCI Executive member (1977-1981) and a member of the Drugs Technical Advisory Board, Ministry of Health, Government of India (1978-1983). He was President of Association of Pharmaceutical Teachers of India (1974 ,1975). He was a member of the standing committee on Pharmaceutical Education, Federation of Asian Pharmaceutical Association (1976-1978) and Committee on Education in Medicinal Chemistry, International Union of Pure and Applied Chemistry.
Harkishan Singh was the President, India Pharmaceutical Congress, thirty third session, Jaipur, 1981. He had delivered Panjab University Pharmaceutical Sciences Oration, Chandigarh, 1998; Bawa Kartar Singh Memorial Lecture, Department of Chemistry, Panjab University, Chandigarh, 1992-1993; Pharmacy Department Silver Jubilee Lecture, Andhra University, Waltair, 1987; Professor M.L. Khorana Memorial Lecture, Indian Pharmaceutical Association, Bombay, 1984.
Research and education had been a lifetime passion with Professor Singh. He has done extensive research in Medicinal and Pharmaceutical Chemistry. Forty-eight doctorate and master theses were completed under his supervision. His primary areas of research had been natural products and heterosteroids. The medicinal plant studied by Professor Singh and his
group were Asteracantha longifolia nees (V.V Parashar), Strychnos potatorum Linn. (V.K. Kapoor), Erythrina Subrosa Roxb and other Erythrina species (A.S Chawla). He was also interested on geometrical enantiomerism which was demonstrated through resolution of (tropinone oxime (B.K. Razdan).
Later, work on the design and synthesis of bis-onium steroids as potential neuromuscular blocking agents was initiated at Panjab University which led to the discovery of Chandonium iodide (HS -310) (D.P. Jindal) after the name of Chandigarh city and other related analogues (T.R. Bhardwaj). After detailed follow-up, toxicity and clinical studies, the drug was cleared by the Ministry of Health, Government of India, for manufacture and clinical use. This synthetic neuromuscular blocker is the crowning feature of research of nearly three decades.
Professor Singh's publications include 21 books (including 9 history monographs); 6 books chapters and 16 other review papers. He had 125 original research papers in Medicinal Chemistry, more than 65 research papers on pharmaceutical history, over hundred articles on pharmaceutical education, professional issues and other topics. Fourteen patents had been obtained for his work on heterosteroids.
Professor Singh had delivered several invited lectures at Institutions and conferences within India, United States of America, United Kingdom, Canada and China. He delivered invited lectures at the Harvard Medical School and at the International Symposium on Molecular Structure (1986) sponsored by the International Union of Crystallography at Beijing, China.
His major research interest however, remained on heterosteroids. Professor Singh's research on heterosteroids was started in 1958 as Post-doctoral Research Fellow in Pharmaceutical chemistry with Dr. Norman J Doorenbos, University of Maryland, USA.
After his retirement in 1988, Prof. Singh revived his interest in the study of history of Pharmacy in India. He had collected rare archival material through his visits to different libraries in India and abroad. Unfortunately, Mrs. Singh passed away in 1998. With great courage and willpower to overcome the grief he continued his research on history of pharmacy in India and also participated in other professional activities. He has organized his collection appropriately into over twelve hundred volumes.
It is rare that new drugs get discovered in the University laboratories. Candocuronium is the International Non-proprietary Name (INN) given to the drugs by the World Health Organization, Geneva.
Tribute
40
PERSONAL ASSOCIATIONS AND VIEWS
Professor Harkishan Singh was known to me since 1968 when I joined University Institute of Pharmaceutical Sciences (Formerly Department of Pharmaceutical Sciences), Panjab University, Chandigarh, for my B. Pharm degree. However, my close association with him started in July, 1972 during my M. Pharm 2nd year, which I completed in 1973. Working under his guidance has not only motivated but also enhanced my passion for research. The interest in the exploration of science further deepened when I joined doctoral program, as Senior Research Fellow (CSIR) again under his supervision. During my Ph.D., I joined parent Institute as lecturer in Pharmaceutical Chemistry in September, 1976. In 1978, I was awarded Ph.D. degree in the Faculty of Medicine. Five Indian patents and more than 10 research papers had been published out of my M. Pharm and Ph.D. work under his supervision. Since then my association with my mentor became stronger and stronger, over a span of around 48 years.
Professor Singh was always keen to derive newer techniques in imparting training at the post graduate level. He introduced workshop system of imparting instructions in which students were made to take active part in the process of learning.
Professor Singh was a person with strong convictions and firm views, on which he never compromised. He was a voracious reader and a prolific writer. For each book or journal, he read, he kept a record of the passages that stirred his mind and soul. As a lover of words and phrases, he tried to use them appropriately in his writings. He always kept himself intellectually informed and mentally sound.
Professor Singh had great reverence to his teachers. He derived inspiration from those who made significant contribution to science and society. This is reflected in the dedication of books authored by him to the memory of his teachers.
Professor Singh had been instrumental in bringing up the University Institute of Pharmaceutical Sciences (UIPS), Panjab University to its present status of foremost Centre of Education and Research in Pharmaceutical Sciences in the country.
Through his research, many unknown facts have been rediscovered. As per his will, Prof. Singh transferred his library to the National Heritage Centre, National Institute of Pharmaceutical Education and Research, SAS Nagar (Mohali). Those who are interested to further explore history of pharmacy can make use of this huge rare collection of Archival material and documents which is available at the National Heritage Centre.
Pharmacy profession will remain indebted to Professor Harkishan Singh forever for his incessant hard work, significant contribution and foresigh-tedness in the upliftment of the profession.
“We pray to the Almighty to impart peace to the departed soul and give enough courage and strength to his family members to bear the irreparable loss.”
Future generation of pharmacy professionals would continue to derive inspiration from the deeds and services rendered to the pharmacy profession by this great educationist and researcher.
On my first day with Professor Singh, he enumerated three qualities which are prerequisite for the good researcher- honesty, hard work and ingenuity, in that order. His advice to his students in general was, “to own your country and work for it”.
The better status of Pharmacy profession in India as a whole is the result of sustained and collective efforts made during last 60 years by many Pharmaceutical luminaries and intellectuals including the substantial efforts of Professor Singh. The primary professionals struggled for almost four decades for the establishment of Central Institute of Pharmacy. Professor Singh kept on lecturing and writing on the subjects which are well documented. He was instrumental in the establishment and academic structuring of National Institute of Pharmaceutical Education and Research at S.A.S. Nagar (Mohali) in 1991.
IPGA NEW MEMBERS
41
Photographs of some of the new members couldn't be printed due to Due to Non Availability of High Resolution Photograph.
All such members are requested to forward soft copy of their photographs at [email protected] alongwith their Name and LM Number.
6701
Mr. Mahebbor Rahaman
6702
Mr. Sukhendu Mondal
6703
Mr. Partha Saha
6704
Mr. Gourav Sanajdar
6705
Mr. Goutam Roy
6706
Mr. Prokash Halder
6707
Mr. Santanu Prosad Dutta
6708
Mr. Sudip Kumar Ganguly
6709
Mr. Rajiul Alam
6710
Mr. Ratan Majumder
6711
Mr. Amit Kumar Ghosh
6712
Mr. Koushik Maity
6713
Ms. Sayanika Ghosh
6714
Dr. Arti Singh Singh
6715
Mr. Pratham Bhatia
6716
Ms. Nancy
6717
Mr. Sehajpreet Singh
6718
Mr. Piyush
6719
Ms. Himani Yadav
6720
Ms. Bhawna Bansal
6721
Ms. Bhavika
6722
Mr. Rahul Dagar
6723
Ms. Sruthy Varghese
6724
Mrs. Anita Kurup
6725
Ms. Aleesha Mathew
6726
Mr. Vaibhav Goel
6727
Ms. Shivam Sharma
6728
Ms. Tanya Agarwal
6729
Ms. Bhavya
6730
Mr. Himanshu Sachdeva
6731
Ms. Alishah Raza
6732
Mr. Aryan Sharma
6733
Mr. Neeraj Kumar
6734
Ms. Smitika Mitra
6735
Ms. Afifa Akram
6736
Ms. Shreya Satija
6737
Mr. Sarthak Yadav
6738
Mr. Sanskar Gupta
6739
Mr. Tushar Dudeja
6740
Mr. Avinash Prasad Verma
6741
Ms. Oshien Gole
6742
Ms. Mansi Sharma
6743
Ms. Vidya
6744
Mr. Ilhan Ahmed Khan
6745
Ms. Priya Tanwar
6746
Ms. Priyanshi Sharma
6747
Mr. Laxit K Bhatt
6748
Ms. Akanksha Singh
6749
Ms. Simran Dixit
6750
Ms. Apoorvi Suri
6751
Ms. Jhalak Verma
6752
Ms. Shutkirti Bharti
6753
Mr. Gaurav Kr. Burman
6754
Mr. Ravindra P. Gupta
6755
Mr. Puru Tuteja
6756
Ms. Priyansha Bhatia
IPGA NEW MEMBERS
42
6757
Mr. Syed Ali H. Zaidi
6758
Mr. Raushan Kumar
6759
Mr. Dipesh Raj Singh
6760
Mr. Nikhil Kumar Pathak
6761
Mr. Subhash Chandra Giri
6762
Mr. Amriendra Kumar
6763
Mr. Deepak Kumar
6764
Ms. Chandni
6765
Mr. Divyanshu Raj
6766
Mr. Manish Kumar
6767
Mr. Nitish Kumar
6768
Mr. Ankit Kumar
6769
Mr. Mukul Kumar
6770
Mr. Rajan Kumar Paswan
6771
Mr. Ritesh Kumar
6772
Ms. Jaya Singh
6773
Ms. Gunjan Kumari
6774
Ms. Km Sarika
6775
Ms. Tanu Ranjan
6776
Dr. Narendra K. Nyola
6777
Dr. Mujeebur Rahman
6778
Dr. Suresh Choudhary
6779
Dr. Shivli Nomani
6780
Dr. Gazala Parveen
6781
Dr. Yogendra Singh
6782
Dr. William A. Sundar
6783
Dr. Jeyaram B. Jeyabalan
6784
Mr. Chandra K. Sharma
6785
Ms. Nidhi Verma
6786
Mr. Shailesh Kumar Singh
6787
Mr. Sahaj Chhabra
6788
Mr. Dhruv Sharma
6789
Ms. Jyoti
6790
Mr. Sandeep Chopra
6791
Ms. Asra Jabeen
6792
Mr. Abhinav Mittal
6793
Mr. Naman Kumar Gupta
6794
Mr. Rajesh Kumar
6795
Mr. Ramveer Singh Rana
6796
Mr. Himansu Chopra
6797
Mr. Sundeep K. Sharma
6798
Mr. Prabin Kumar Shahu
6799
Mr. Deepanshu Mishra
6800
Mr. Akshay Sachdeva
6801
Mr. Yashasvi Vaid
6802
Dr. Nagaraju Pappula
6803
Ms. Palak Jain
6804
Ms. Kawal Jeet Kaur
6805
Ms. Sreetama Moitra
6806
Ms. Puspita Roy
6807
Mr. Shovan Naskar
6808
Mr. Sattik Mallick
6809
Mr. Soumyadip Ghosh
6810
Mr. Souvik Sarkar
6811
Ms. Neha Biswas
6812
Ms. Saptami Goswami
Photographs of some of the new members couldn't be printed due to Due to Non Availability of High Resolution Photograph.
All such members are requested to forward soft copy of their photographs at [email protected] alongwith their Name and LM Number.
IPGA NEW MEMBERS
43
* Due to Non Availability of High Resolution Photograph, we could not print it. Kindly forward soft copy of photographs at [email protected] alongwith your Name and LM Number.
6813
Mr. Manu Singhai
6814
Ms. Ritu Saini
6815
Mr. Anas Saifi
6816
Mr. Sachin Ashok Kamble
6817
Mr. Vivek P. Khedkar
6818
Mr. Aniket Upla
6819
Mr. Mukesh Bhardwaj
6827
Ms. Navjit Kaur
6828
Ms. Gurminder Kaur
6829
Ms. Ritu Saini
6830
Ms. Chahanpreet Kaur
6831
Ms. Harpreet Kaur
6832
Ms. Ramandeep Kaur
6833
Mr. Tapan Kumar Mahto
6820
Mrs. Swrupa Arvapalli
6821
Mrs. Shyamala
6822
Mr. Vikas P. Singh
6823
Mr. Shiv K. Srivastava
6824
Dr. Ajay Singh Kushwah
6825
Dr. Rahul Kumar Sharma
6826
Mr. Satvir Singh
6834
Dr. Parimalakrishnan
6835
Mr. Anindya Banerjee
6836
Mr. Kasi S
6837
Dr. Satish Shrishail Karoli
6838
Dr. Limce Thampi
6839
Mr. Pardeep K. Suhag
6840
Dr. Gini E J
I promise to do all I can to protect and improve the physical and moral well-being of society, holding the health and safety of my community above other considerations. I shall uphold the laws and standards governing my profession avoiding all forms of misrepresentation and I shall safeguard the distribution of medical and potent substances.
Knowledge gained about patients I shall hold in confidence and never divulge unless compelled to do so by law.
I shall strive to perfect and enlarge my knowledge the better to contribute to the advancement of pharmacy and the public health.
I furthermore promise to maintain my honour and credit in all transactions and by my conduct never to bring discredit to myself or my profession nor to do anything to diminish the trust reposed in my professional brethern.
May I prosper and live long in favour as I keep and hold to this my oath but should I violate these sacred promises may the reverse by my lot.
To aid, assist & finance, establish and run, conduct conventions, scholarships, training, seminars, coaching, placements, consultancies, research projects, and such other activities as may be necessary for upliftment of members of Indian Pharmacy Graduates’ Association and for the general public welfare particularly of women, children, senior citizens and handicapped persons of all castes and creeds.
Mission
The IPGA Welfare Trust has decided to contribute a sum of Rs. 15000/- for IPGA Welfare Trust sponsored Conference/Seminar/Workshop* organised by an institute imparting degree course in pharmacy for the welfare of Pharmacy Graduates. ( For sponsorship write to the managing trustee : [email protected] with detailed proposal)
Anil Kr. Negi9310053001
P.K. Jaggi9811168062
Bhanu Dua9811072757
Arun Garg 8470046553
S.L. Nasa9313294423
P.P. Sharma9871471515
Atul Kr. Nasa9871318288
S.L. Sobti9811042169
Trustees
RECENT SPONSORSHIPS BY IPGA WELFARE TRUST
Opinions expressed in IPGA TODAY are those of the authors and do not necessarily reflect the views of Indian Pharmacy Graduates’ Association.All rights reserved. Material from IPGA TODAY may be reproduced without written permission provided the source is acknowledged.
Regd. Off. : F-2, A-Block, DDA Shopping Complex, Meera Bagh, New Delhi-110087, India
Have you moved ?If your correspondence address has changed, please forward your new address to IPGA-TODAY.
Edited and Published by : Mr. P.K. Jaggi, on behalf of the Indian Pharmacy Graduates’ Association, F-2, A-Block, DDA Shopping Complex, Meera Bagh, New Delhi-110087, India
IPGA WELFARE TRUST Established : March 2009
Bharat Bhushan9810777569
Vijay Bhalla9810540434
44
(Rupees)
Managing TrusteeManaging TrusteeManaging Trustee
4. SANKHA BHATTACHARYA (STUDENT), B.C.D.A. COLLEGE OF PHARMACY, WEST BENGAL 25000 08/03/2020
1. ASBASJSM COLLEGE OF PHARMACY, BELA 25000 08/03/2020
2. SGT COLLEGE OF PHARMACY, GURUGRAM 25000 08/03/2020
3. SAT KAIVAL COLLEGE OF PHARMACY, SARSA, GUJARAT 25000 08/03/2020
S.No. Name of The Institution Amount Approved
in RupeesDate of
Approval